Saturday, October 26, 2013 Cincinnati, Ohio

12th Annual Psychopharmacology Update: Emerging Trends and Best Practices in Pharmacotherapy

Saturday October 26, 2013
Marriott Kingsgate Hotel, Cincinnati, Ohio
6:30 - 7:15 a.m. Registration and Breakfast
7:15 - 7:30 a.m. Welcome and Introduction
Henry A. Nasrallah, MD
7:30 - 8:30 a.m. Breakfast Symposium (Non-CME)
Identifying an Option to Consider for Your Patients with Schizophrenia
Andrew Cutler, MD
Sponsored by: Otsuka America Pharmaceutical, Inc. and Lundbeck
8:30 - 9:30 a.m. Is There a Rational Algorithm for Pharmacotherapy for Major Depression?
Michael Thase, MD
9:30 - 10:30 a.m. Mood Stabilizer or Atypical Antipsychotic: What to Use in First–Episode VS Multiple–Episode Bipolar Mania?
Roger McIntyre, MD
10:30 - 10:45 a.m. Break/Exhibits
10:45 - 11:45 a.m. Neuroinflammation and Oxidative Stress During Acute Episodes: Implications for Pharmacotherapy of Schizophrenia, Bipolar Disorder and Major Depression
Henry A. Nasrallah, MD
11:45 - 12:45 p.m. An Update on the Best Practices to Manage Eating Disorders
Anne Marie O'Melia, MS, MD, FAAP
12:45 - 2:15 p.m. Luncheon Symposium (non-CME)
A New Treatment Option for Bipolar Depression in Adults: Pivotal Clinical Data
Peter Weiden, MD
Sponsored by: Sunovion
2:15 - 2:30 p.m. Dessert Break/Exhibits
2:30 – 3:30 p.m. Should Benzodiazepines Be Used At All: What is the Best Practice for the Treatment of Anxiety?
James Jefferson, MD
3:30 - 4:30 p.m. Long-acting Injectable Antipsychotics and Clozapine: Under-use to Best Practice
Peter Weiden, MD
4:30 - 5:30 p.m. The Emerging Role of Omega-3 Fatty Acids in Treating Major Psychiatric Disorders.
Robert McNamara, PHD
5:30 - 6:00 p.m. Review of Key Points and Conclusions
6:00 p.m. Adjournment

Agenda is subject to change. Please check back for updates.